Adgero Biopharmaceuticals Appoints John Liatos as Chief Financial Officer
PRINCETON, NJ--(Marketwired - October 25, 2017) - Adgero Biopharmaceuticals Holdings, Inc. ("Adgero" or the "Company"), a privately-held biopharmaceutical company leveraging its late stage photodynamic therapy ("PDT") platform …